Cologne, Germany: Pfizer today announced the preliminary results of a human trial of a vaccine against COD 19, but few people know that a German-Turkish couple is playing a key role behind it.
Over Shaheen, 55, and his wife, Ozlam Toriki, 53, are both scientists by profession who have an international reputation for cancer immunotherapy.
Read More:Russia also claims to have developed a vaccine with 90% positive results
The New York-based Pfizer company said in a statement that the vaccine had been tested on more than 43,000 people, including Americans, Germans and Turks, but that in fact another German company, Bayon Tech, had a very successful role in this important vaccine. Has paid The company was set up by a Turkish couple who took refuge in Germany.
Read this: American and German companies develop corona vaccine
Based in Mainz, Germany, Biontech has emerged as one of the largest companies to conduct large-scale clinical trials for the coronavirus vaccine, and so far the new vaccine has proved to be 90% effective and has no side effects. The effects did not occur.
Overseas is currently one of the 100 richest people in Germany, and his wife is one of the company’s board members. Last year, Bayon Tech had assets of 4. 4.6 billion and last week its shares reached 21 21 billion. This pair is prominent in the emerging treatment of cancer, immunotherapy.
Read More:Scientists have successfully developed snake venom in a laboratory for the first time
The company was founded in 2008 and has grown a lot so far, but the overs are still very humble and simple. They come to important business meetings wearing plain jeans and riding bicycles with bicycle helmets and bags on their backs.
Over Shaheen wanted to become a doctor and became a doctor at a hospital in Cologne, Germany, where he met Ozlum. The two are also obsessed with scientific research and were engaged in scientific research in a laboratory in Hamburg, Germany, on the day of their wedding.
That’s why they’ve done extensive research on the body’s immune system fighting cancer, paving the way for cancer immunotherapy.
In 2001, he founded Guinea Med, an organization that worked on cancer-fighting antibodies, and the same experiment was used to develop the corona vaccine, but in 2016 the company was sold to Japan for about ً 1.4 billion. ۔
The two then founded another company, Bayon Tech. This time, Shaheen and Ozlam used mRNA (messenger DNA molecule) to fight cancer. After the Corona epidemic broke out in Wuhan, China, in January 2020, Ovar Shaheen began working on a vaccine from the mRNA.
Under a project called ‘Light Speed’, Bayon Tech hired a staff of 500 experts to conduct research to find effective compounds against Code 19. Now the fruit of all this effort is in front of the world in the form of this vaccine.